Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-18T03:56:27.656Z Has data issue: false hasContentIssue false

Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated Diarrhea

Published online by Cambridge University Press:  02 January 2015

Clarwyn Yip
Affiliation:
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Mark Loeb*
Affiliation:
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, CanadaHamilton Civics Hospital, Hamilton, Ontario, Canada
Suzette Salama
Affiliation:
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Lorraine Moss
Affiliation:
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Jan Olde
Affiliation:
Hamilton Civics Hospital, Hamilton, Ontario, Canada
*
Hamilton Health Sciences Corporation, 711 Concession St, Hamilton, Ontario L8V1C3, Canada

Abstract

Objective:

To determine modifiable risk factors for nosocomial Clostridium difficile-associated diarrhea (CDAD).

Design:

Case-control study.

Setting:

300-bed tertiary-care hospital.

Participants:

Hospital inpatients present during the 3-month study period.

Methods:

Case-patients identified with nosocomial CDAD over the study period were compared to two sets of control patients: inpatients matched by age, gender, and date of admission; and inpatients matched by duration of hospital stay. Variables including demographic data, comorbid illnesses, antibiotic exposure, and use of gastrointestinal medications were assessed for case- and control-patients. Conditional logistic regression was performed to identify risk factors for nosocomial CDAD.

Results:

27 case-patients were identified and were compared to the two sets of controls (1:1 match for each comparison set). For the first set of controls, use of ciprofloxacin (odds ratio [OR], 5.5; 95% confidence interval [CI95], 1.2-24.8; P=.03) was the only variable that remained significant in the multivariable model. For the second set of controls, prior exposure to cephalosporins (OR, 6.7; CL,5, 1.3-33.7; P=.02) and to ciprofloxacin (OR, 9.5; CI95, 1.01-88.4; P=.05) were kept in the final model.

Conclusions:

Along with cephalosporins, prior quinolone use predisposed hospitalized patients to nosocomial CDAD. Quinolones should be used judiciously in acute-care hospitals, particularly in those where CDAD is endemic.

Information

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable